The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world. Drug manufacturers must adeptly navigate ever-changing regulatory ...

The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions.

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...